<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>건강과 대안 &#187; Dr Neil Mabbott</title>
	<atom:link href="http://www.chsc.or.kr/tag/Dr%20Neil%20Mabbott/feed" rel="self" type="application/rss+xml" />
	<link>http://www.chsc.or.kr</link>
	<description>연구공동체</description>
	<lastBuildDate>Mon, 13 Apr 2026 01:34:28 +0000</lastBuildDate>
	<language>ko-KR</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.5.2</generator>
		<item>
		<title>[광우병] 젊은 사람들이 인간광우병에 더 잘 걸리는 이유?</title>
		<link>http://www.chsc.or.kr/?post_type=reference&#038;p=2275</link>
		<comments>http://www.chsc.or.kr/?post_type=reference&#038;p=2275#comments</comments>
		<pubDate>Wed, 08 Sep 2010 18:24:58 +0000</pubDate>
		<dc:creator>건강과대안</dc:creator>
				<category><![CDATA[광우병]]></category>
		<category><![CDATA[식품 · 의약품]]></category>
		<category><![CDATA[BSE]]></category>
		<category><![CDATA[CJD]]></category>
		<category><![CDATA[Dr Neil Mabbott]]></category>
		<category><![CDATA[vCJD]]></category>
		<category><![CDATA[감수성]]></category>
		<category><![CDATA[나이]]></category>
		<category><![CDATA[변형 프리온 단백질]]></category>
		<category><![CDATA[인간광우병]]></category>
		<category><![CDATA[프리온 단백질]]></category>

		<guid isPermaLink="false">http://www.chsc.or.kr/?post_type=reference&#038;p=2275</guid>
		<description><![CDATA[젊은 사람들이 나이든 사람들에 비해 인간광우병에 민감한 이유를 밝히려는 연구결과 중 2009년 10월 영국 에딘버러대학교의 로슬린연구소의 Neil Mabbott 박사팀이 [면역학회지(The Journal of Immunology)]에 발표한 논문의 요약문입니다. &#160; 로슬린연구소의 [...]]]></description>
				<content:encoded><![CDATA[<p>젊은 사람들이 나이든 사람들에 비해 인간광우병에 민감한 이유를 밝히려는 연구결과 중 2009년 10월 영국 에딘버러대학교의 로슬린연구소의 Neil Mabbott 박사팀이 [면역학회지(<FONT size=2>The Journal of Immunology)]에 </FONT>발표한 논문의 요약문입니다.<br />
<DIV>&nbsp;</DIV><br />
<DIV>로슬린연구소의 연구자들은&nbsp;쥐 실험을 통해 나이에 따른 소포성 수지상 세포 (follicular dendritic cells)와 프리온 단백질의 상호작용에 대한 연구결과를 발표했습니다.<BR><BR>변형 프리온은 중추신경계로 퍼지기 전에 비장, 림파구, 편도 등 면역계의 일부인 림프조직에 축적되는데, Neil Mabbott를 비롯한 로슬린 연구소의 학자들은 프리온은 필수불가결하게 면역계의 특별한 세포인 소포성 수지상 세포 (follicular dendritic cells)를&nbsp; &#8220;납치(hijack)&#8221;하는 것을 확인했습니다.(변형 프리온 단백질이 소포성 수지상 세포와 반드시 결합하여 그 세포에서 축적되고 복제됩니다)<BR><BR>그러나 나이 든 쥐에서는 소포성 수지상 세포가 손상된(감소된) 것이 확인됐습니다.<BR><BR>광우병과 소포성 수지상 세포 (follicular dendritic cells)의 연관성은 예전에 [네이처]에도 발표된 바가 있습니다.<BR><BR>논문의 영문 요약문과 출처는 아래와 같습니다.</DIV><br />
<DIV>&nbsp;</DIV><br />
<DIV>==============================<WBR>===================</DIV><br />
<DIV><br />
<H2>The Effects of Host Age on Follicular Dendritic Cell Status Dramatically Impair Scrapie Agent Neuroinvasion in Aged Mice<A name=12aef841c4776240_RFN1></A><SUP><FONT size=3>1</FONT></SUP></H2><EM>Karen L. Brown,<A name=12aef841c4776240_RFN2></A><FONT size=2><SUP>2</SUP><SUP>*</SUP></FONT> Gwennaelle J. Wathne,<SUP><FONT size=2>*</FONT></SUP> Jill Sales,<SUP><IMG border=0 alt={dagger} src="http://www.jimmunol.org/math/dagger.gif"></SUP> Moira E. Bruce,<SUP><FONT size=2>*</FONT></SUP> and Neil A. Mabbott<A name=12aef841c4776240_RFN2></A><FONT size=2><SUP>2</SUP><SUP>*</SUP></FONT> </EM><br />
<P><FONT size=-1><SUP>*</SUP>The Roslin Institute and Royal (Dick) School of Veterinary Sciences, University of Edinburgh, Roslin, United Kingdom; and <SUP><IMG border=0 alt={dagger} src="http://www.jimmunol.org/math/dagger.gif"></SUP>Biomathematics &#038; Statistics Scotland, Edinburgh, United Kingdom </FONT></P><br />
<P>출처 : Published online September 28, 2009 <BR><FONT size=-1><EM>The Journal of Immunology</EM>, 2009, 183, 5199 -5207 <BR><A _onclick="return top.js.OpenExtLink(window,event,this)" href="http://www.jimmunol.org/cgi/content/abstract/183/8/5199" target=_blank>http://www.jimmunol.org/cgi/<WBR>content/abstract/183/8/5199</A><BR></FONT><FONT size=-1>doi:10.4049/jimmunol.0802695 </FONT><BR></P><br />
<P>Following peripheral exposure, many transmissible spongiform<SUP><FONT size=2> </FONT></SUP>encephalopathy (TSE) agents accumulate first in lymphoid tissues<SUP><FONT size=2> </FONT></SUP>before spreading to the CNS (termed neuroinvasion) where they<SUP><FONT size=2> </FONT></SUP>cause neurodegeneration. Early TSE agent accumulation upon follicular<SUP><FONT size=2> </FONT></SUP>dendritic cells (FDCs) in lymphoid follicles appears critical<SUP><FONT size=2> </FONT></SUP>for efficient neuroinvasion. Most clinical cases of variant<SUP><FONT size=2> </FONT></SUP>Creutzfeldt-Jakob disease have occurred in young adults, although<SUP><FONT size=2> </FONT></SUP>the reasons behind this apparent age-related susceptibility<SUP><FONT size=2> </FONT></SUP>are uncertain. Host age has a significant influence on immune<SUP><FONT size=2> </FONT></SUP>function. As FDC status and immune complex trapping is reduced<SUP><FONT size=2> </FONT></SUP>in aged mice (600 days old), we hypothesized that this aging-related<SUP><FONT size=2> </FONT></SUP>decline in FDC function might impair TSE pathogenesis. We show<SUP><FONT size=2> </FONT></SUP>that coincident with the effects of host age on FDC status,<SUP><FONT size=2> </FONT></SUP>the early TSE agent accumulation in the spleens of aged mice<SUP><FONT size=2> </FONT></SUP>was significantly impaired. Furthermore, following peripheral<SUP><FONT size=2> </FONT></SUP>exposure, none of the aged mice developed clinical TSE disease<SUP><FONT size=2> </FONT></SUP>during their lifespans, although most mice displayed histopathological<SUP><FONT size=2> </FONT></SUP>signs of TSE disease in their brains. Our data imply that the<SUP><FONT size=2> </FONT></SUP>reduced status of FDCs in aged mice significantly impairs the<SUP><FONT size=2> </FONT></SUP>early TSE agent accumulation in lymphoid tissues and subsequent<SUP><FONT size=2> </FONT></SUP>neuroinvasion. Furthermore, the inefficient neuroinvasion in<SUP><FONT size=2> </FONT></SUP>aged individuals may lead to significant levels of subclinical<SUP><FONT size=2> </FONT></SUP>TSE disease in the population.<SUP><FONT size=2> </FONT></SUP><br />
<P><A name=12aef841c4776240_></A>The costs of publication of this article were defrayed in part<SUP><FONT size=2> </FONT></SUP>by the payment of page charges. This article must therefore<SUP><FONT size=2> </FONT></SUP>be hereby marked <I>advertisement</I> in accordance with 18 U.S.C.<SUP><FONT size=2> </FONT></SUP>Section 1734 solely to indicate this fact.<SUP><FONT size=2> </FONT></SUP><br />
<P><A name=12aef841c4776240_FN1></A><SUP><FONT size=2>1</FONT></SUP> This work was supported by funding from the European Commission,<SUP><FONT size=2> </FONT></SUP>UK Biotechnology and Biological Sciences Research Council, and<SUP><FONT size=2> </FONT></SUP>the Medical Research Council.<SUP><FONT size=2> </FONT></SUP><br />
<P><A name=12aef841c4776240_FN2></A><SUP><FONT size=2>2</FONT></SUP> Address correspondence and reprint requests to Dr. Karen L.<SUP><FONT size=2> </FONT></SUP>Brown and Dr. Neil A. Mabbott, The Roslin Institute and Royal<SUP><FONT size=2> </FONT></SUP>(Dick) School of Veterinary Sciences, University of Edinburgh,<SUP><FONT size=2> </FONT></SUP>Roslin, Midlothian EH25 9PS, U.K. E-mail: <SPAN><A _onclick="return top.js.OpenExtLink(window,event,this)" href="mailto:karen.brown@roslin.ed.ac.uk" target=_blank>karen.brown@roslin.ed.ac.uk</A></SPAN><SPAN></SPAN> <SUP></SUP>and <SPAN><A _onclick="return top.js.OpenExtLink(window,event,this)" href="mailto:neil.mabbott@roslin.ed.ac.uk" target=_blank>neil.mabbott@roslin.ed.ac.uk</A></SPAN><SPAN></SPAN> <SUP></SUP><br />
<P><A name=12aef841c4776240_FN3></A><SUP><FONT size=2>3</FONT></SUP> Abbreviations used in this paper: TSE, transmissible spongiform<SUP><FONT size=2> </FONT></SUP>encephalopathy; FDC, follicular dendritic cell; PrP, prion protein;<SUP><FONT size=2> </FONT></SUP>vCJD, variant Creutzfeldt-Jakob disease; BSE, bovine spongiform<SUP><FONT size=2> </FONT></SUP>encephalopathy; CR, complement receptor; i.c., intracerebral;<SUP><FONT size=2> </FONT></SUP>TH, tyrosine hydroxylase; PK, proteinase K.<SUP><FONT size=2> </FONT></SUP><br />
<P><A name=12aef841c4776240_FN4></A><SUP><FONT size=2>4</FONT></SUP> The online version of this article contains supplemental material.<SUP><FONT size=2> <BR><BR>================================<BR></P><br />
<P><IMG align=right src="/images/people/neil.mabbott.jpg"><br />
<H1>Dr Neil Mabbott </H1><br />
<P><A href="mailto:neil.mabbott@roslin.ed.ac.uk">neil.mabbott@roslin.ed.ac.uk</A> </P><br />
<P>Identification of critical cells and molecules involved in the delivery of TSE agents from the site of infection to the brain. </P><br />
<P>출처 : <A href="http://www.roslin.ac.uk/research/people.php/Neil.Mabbott">http://www.roslin.ac.uk/research/people.php/Neil.Mabbott</A></P><br />
<DIV id=clear></DIV><br />
<DIV><br />
<H2>Contact Details</H2><br />
<P><br />
<P>Dr Neil Mabbott<BR>Group Leader <BR>Neuropathogenesis Division</P><br />
<P>The Roslin Institute and R(D)SVS, University of Edinburgh<BR>Roslin Biocentre<BR>Roslin Institute <BR>Midlothian <BR>EH25 9PS</P><br />
<P>Tel: 0131 527 4200<BR>Fax: 0131 440 0434</P><br />
<P>e-mail: <A href="mailto:neil.mabbott@roslin.ed.ac.uk">neil.mabbott@roslin.ed.ac.uk</A><BR></P></DIV></FONT></SUP></DIV></p>
]]></content:encoded>
			<wfw:commentRss>http://www.chsc.or.kr/?post_type=reference&#038;p=2275/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
